PAVmed Statistics
Share Statistics
PAVmed has 11.07M shares outstanding. The number of shares has increased by 29.26% in one year.
| Shares Outstanding | 11.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 10.33% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 9.19M |
| Failed to Deliver (FTD) Shares | 95 |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 281.01K, so 2.54% of the outstanding shares have been sold short.
| Short Interest | 281.01K |
| Short % of Shares Out | 2.54% |
| Short % of Float | 3.06% |
| Short Ratio (days to cover) | 9.07 |
Valuation Ratios
The PE ratio is -0.46 and the forward PE ratio is -0.78.
| PE Ratio | -0.46 |
| Forward PE | -0.78 |
| PS Ratio | 12.15 |
| Forward PS | 0.5 |
| PB Ratio | -0.55 |
| P/FCF Ratio | -0.57 |
| PEG Ratio | n/a |
Enterprise Valuation
PAVmed Inc. has an Enterprise Value (EV) of 58.88M.
| EV / Earnings | -0.92 |
| EV / Sales | 24.01 |
| EV / EBITDA | -0.78 |
| EV / EBIT | -0.86 |
| EV / FCF | -1.13 |
Financial Position
The company has a current ratio of 0.45, with a Debt / Equity ratio of -0.82.
| Current Ratio | 0.45 |
| Quick Ratio | 0.44 |
| Debt / Equity | -0.82 |
| Total Debt / Capitalization | -458.93 |
| Cash Flow / Debt | -1.18 |
| Interest Coverage | -116.8 |
Financial Efficiency
Return on equity (ROE) is 1.19% and return on capital (ROIC) is -278.44%.
| Return on Equity (ROE) | 1.19% |
| Return on Assets (ROA) | -1.94% |
| Return on Capital (ROIC) | -278.44% |
| Revenue Per Employee | 22.92K |
| Profits Per Employee | -599.77K |
| Employee Count | 107 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 11.91 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -79.57% in the last 52 weeks. The beta is 0.69, so PAVmed 's price volatility has been higher than the market average.
| Beta | 0.69 |
| 52-Week Price Change | -79.57% |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 1.38 |
| Relative Strength Index (RSI) | 34.56 |
| Average Volume (20 Days) | 60.15K |
Income Statement
In the last 12 months, PAVmed had revenue of $2.45M and earned -$64.17M in profits. Earnings per share was $-9.16.
| Revenue | 2.45M |
| Gross Profit | -3.97M |
| Operating Income | -68.80M |
| Net Income | -64.17M |
| EBITDA | -75.74M |
| EBIT | -68.80M |
| Earnings Per Share (EPS) | -9.16 |
Balance Sheet
The company has $19.64M in cash and $48.73M in debt, giving a net cash position of -$29.09M.
| Cash & Cash Equivalents | 19.64M |
| Total Debt | 48.73M |
| Net Cash | -29.09M |
| Retained Earnings | -294.43M |
| Total Assets | 30.55M |
| Working Capital | -35.43M |
Cash Flow
In the last 12 months, operating cash flow was -$52.04M and capital expenditures -$242.00K, giving a free cash flow of -$52.28M.
| Operating Cash Flow | -52.04M |
| Capital Expenditures | -242.00K |
| Free Cash Flow | -52.28M |
| FCF Per Share | -7.23 |
Margins
Gross margin is -161.83%, with operating and profit margins of -2.81K% and -2.62K%.
| Gross Margin | -161.83% |
| Operating Margin | -2.81K% |
| Pretax Margin | -3.23K% |
| Profit Margin | -2.62K% |
| EBITDA Margin | -3.09K% |
| EBIT Margin | -2.81K% |
| FCF Margin | -2.13K% |
Dividends & Yields
PAVM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1205.26% |
| FCF Yield | -617.8% |
Analyst Forecast
The average price target for PAVM is $19, which is 2400% higher than the current price. The consensus rating is "Buy".
| Price Target | $19 |
| Price Target Difference | 2400% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Dec 7, 2023. It was a backward split with a ratio of 1:15.
| Last Split Date | Dec 7, 2023 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -11.8 |
| Piotroski F-Score | 4 |